Search - tctmd.com

Displaying 461 - 480 of 499

Sort: Relevancy | Date

News Daily News

RenalGuard Evita la LRA en Pacientes TAVR Mejor que una Solución Salina Estándar

September 22, 2015

Presentation

PROTECT-TAVI: AKI With the RenalGuard System in Patients Undergoing TAVR

Presenter: Marco Barbanti

September 21, 2015

News Daily News

现实中 LVAD 在被认为无法行 PCI 的危重患者中的使用颇具结局前景

L.A. McKeown

August 24, 2015

News Daily News

Real-World LVAD Use Promising in Patients Otherwise Considered Too Sick for PCI

L.A. McKeown

August 24, 2015

News Daily News

El Uso de DAVI en el Mundo Real es Prometedor en Pacientes Considerados, de Otra Forma, Demasiados Enfermos para ser Sometidos a una PCI

L.A. McKeown

August 24, 2015

Presentation

Percutaneous LVAD for High-Risk PCIs:Real-World vs Clinical-Trial Experience

Presenter: Mauricio G. Cohen

August 21, 2015

News Daily News

Subestudio BASKET-PROVE: Los SLF son Mejores que los SMD en Pacientes Ancianos con Arterias Grandes

Yael L. Maxwell

July 29, 2015

News Daily News

BASKET-PROVE 亚组研究：DES 对有大动脉的老年患者的治疗效果优于 BMS

Yael L. Maxwell

July 29, 2015

News Daily News

BASKET-PROVE Substudy: DES Better Than BMS in Elderly Patients With Large Arteries

Yael L. Maxwell

July 29, 2015

Presentation

Improved Outcomes of Elderly Patients Treated With DES vs BMS in Large Coronary Arteries

Presenter: David J. Kruz

July 28, 2015

News Industry News

Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular Disease with NIH Grant

July 28, 2015

News Daily News

研究表明，年满 90 岁患者不应排除 TAVR 方案

Todd Neale

July 27, 2015

News Daily News

Un Estudio Sugiere que Tener 90 Años o Más No Debería de Excluir la TAVR

Todd Neale

July 27, 2015

News Daily News

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

Todd Neale

July 27, 2015

Presentation

Comparison of Outcomes of TAVR in Patients Older than 90 Years vs Younger than 90 Years

Presenter: Yigal Abramowitz

July 24, 2015

News Industry News

Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published in The Lancet

July 23, 2015

News Daily News

ADVANCE结果发布：卒中发生率随着TAVR的进步而降低

Yael L. Maxwell

July 15, 2015

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

News Daily News

ADVANCE Publicado: el Índice de ACV Disminuye a Medida que Evoluciona la TAVR

Yael L. Maxwell

July 15, 2015

Presentation

Incidence and Predictors of Early and Midterm Clinically Relevant Neurological Events After TAVR

Presenter: Johan Bosmans

July 14, 2015

Advertisement

RenalGuard Evita la LRA en Pacientes TAVR Mejor que una Solución Salina Estándar

PROTECT-TAVI: AKI With the RenalGuard System in Patients Undergoing TAVR

现实中 LVAD 在被认为无法行 PCI 的危重患者中的使用颇具结局前景

Real-World LVAD Use Promising in Patients Otherwise Considered Too Sick for PCI

El Uso de DAVI en el Mundo Real es Prometedor en Pacientes Considerados, de Otra Forma, Demasiados Enfermos para ser Sometidos a una PCI

Percutaneous LVAD for High-Risk PCIs:Real-World vs Clinical-Trial Experience

Subestudio BASKET-PROVE: Los SLF son Mejores que los SMD en Pacientes Ancianos con Arterias Grandes

BASKET-PROVE 亚组研究：DES 对有大动脉的老年患者的治疗效果优于 BMS

BASKET-PROVE Substudy: DES Better Than BMS in Elderly Patients With Large Arteries

Improved Outcomes of Elderly Patients Treated With DES vs BMS in Large Coronary Arteries

Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular Disease with NIH Grant

研究表明，年满 90 岁患者不应排除 TAVR 方案

Un Estudio Sugiere que Tener 90 Años o Más No Debería de Excluir la TAVR

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

Comparison of Outcomes of TAVR in Patients Older than 90 Years vs Younger than 90 Years

Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published in The Lancet

ADVANCE结果发布：卒中发生率随着TAVR的进步而降低

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

ADVANCE Publicado: el Índice de ACV Disminuye a Medida que Evoluciona la TAVR

Incidence and Predictors of Early and Midterm Clinically Relevant Neurological Events After TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content